Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-18

Clinical Trial Update: Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic Gliomas [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the safety of combining fluvastatin with celecoxib in glioma (optico-chiasmatic) has completed, focusing on safety and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CELEBREX (Celecoxib)
  • Lescol (fluvastatin)

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Glioma | Phase 1 | Status: COMPLETED